Morgan Stanley’s Aehr Test Systems AEHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.14M | Sell |
165,673
-79,110
| -32% | -$2.53M | ﹤0.01% | 3976 |
|
|
2025
Q4 | $4.94M | Buy |
244,783
+155,516
| +174% | +$3.76M | ﹤0.01% | 4181 |
|
|
2025
Q3 | $2.69M | Sell |
89,267
-113,928
| -56% | -$2.47M | ﹤0.01% | 4598 |
|
|
2025
Q2 | $2.63M | Buy |
203,195
+23,804
| +13% | +$227K | ﹤0.01% | 4530 |
|
|
2025
Q1 | $1.31M | Sell |
179,391
-100,961
| -36% | -$1.12M | ﹤0.01% | 4870 |
|
|
2024
Q4 | $4.66M | Buy |
280,352
+78,178
| +39% | +$1.04M | ﹤0.01% | 4056 |
|
|
2024
Q3 | $2.6M | Buy |
202,174
+43,725
| +28% | +$632K | ﹤0.01% | 4465 |
|
|
2024
Q2 | $1.77M | Sell |
158,449
-249,848
| -61% | -$2.91M | ﹤0.01% | 4639 |
|
|
2024
Q1 | $5.06M | Sell |
408,297
-42,915
| -10% | -$715K | ﹤0.01% | 3901 |
|
|
2023
Q4 | $12M | Sell |
451,212
-111,120
| -20% | -$3.24M | ﹤0.01% | 3774 |
|
|
2023
Q3 | $25.7M | Buy |
562,332
+125,075
| +29% | +$5.8M | ﹤0.01% | 2196 |
|
|
2023
Q2 | $18M | Buy |
437,257
+51,354
| +13% | +$1.68M | ﹤0.01% | 2581 |
|
|
2023
Q1 | $12M | Buy |
385,903
+41,423
| +12% | +$1.33M | ﹤0.01% | 2974 |
|
|
2022
Q4 | $6.92M | Buy |
344,480
+221,983
| +181% | +$4.75M | ﹤0.01% | 3448 |
|
|
2022
Q3 | $1.73M | Buy |
122,497
+47,199
| +63% | +$635K | ﹤0.01% | 4537 |
|
|
2022
Q2 | $564K | Sell |
75,298
-87,261
| -54% | -$725K | ﹤0.01% | 5356 |
|
|
2022
Q1 | $1.65M | Buy |
162,559
+54,277
| +50% | +$694K | ﹤0.01% | 4657 |
|
|
2021
Q4 | $2.62M | Sell |
108,282
-9,272
| -8% | -$181K | ﹤0.01% | 4356 |
|
|
2021
Q3 | $1.6M | Buy |
117,554
+113,354
| +2,699% | +$814K | ﹤0.01% | 4745 |
|
|
2021
Q2 | $12K | Hold |
4,200
| – | – | ﹤0.01% | 7176 |
|
|
2021
Q1 | $11K | Hold |
4,200
| – | – | ﹤0.01% | 6906 |
|
|
2020
Q4 | $11K | Hold |
4,200
| – | – | ﹤0.01% | 6598 |
|
|
2020
Q3 | $6K | Hold |
4,200
| – | – | ﹤0.01% | 6398 |
|
|
2020
Q2 | $8K | Hold |
4,200
| – | – | ﹤0.01% | 6207 |
|
|
2020
Q1 | $7K | Hold |
4,200
| – | – | ﹤0.01% | 6096 |
|
|
2019
Q4 | $8K | Hold |
4,200
| – | – | ﹤0.01% | 6305 |
|
|
2019
Q3 | $8K | Hold |
4,200
| – | – | ﹤0.01% | 6262 |
|
|
2019
Q2 | $7K | Hold |
4,200
| – | – | ﹤0.01% | 6217 |
|
|
2019
Q1 | $6K | Sell |
4,200
-2,008
| -32% | -$2.71K | ﹤0.01% | 6283 |
|
|
2018
Q4 | $9K | Sell |
6,208
-305
| -5% | -$570 | ﹤0.01% | 6180 |
|
|
2018
Q3 | $14K | Sell |
6,513
-4,762
| -42% | -$11.8K | ﹤0.01% | 6224 |
|
|
2018
Q2 | $27K | Sell |
11,275
-726
| -6% | -$1.79K | ﹤0.01% | 6071 |
|
|
2018
Q1 | $27K | Sell |
12,001
-1,668
| -12% | -$4.23K | ﹤0.01% | 6059 |
|
|
2017
Q4 | $37K | Sell |
13,669
-3,000
| -18% | -$9.5K | ﹤0.01% | 5912 |
|
|
2017
Q3 | $68K | Buy |
16,669
+1,000
| +6% | +$3.59K | ﹤0.01% | 5684 |
|
|
2017
Q2 | $59K | Sell |
15,669
-10,600
| -40% | -$44.7K | ﹤0.01% | 5807 |
|
|
2017
Q1 | $126K | Buy |
26,269
+6,600
| +34% | +$24.8K | ﹤0.01% | 5513 |
|
|
2016
Q4 | $48K | Hold |
19,669
| – | – | ﹤0.01% | 5762 |
|
|
2016
Q3 | $63K | Hold |
19,669
| – | – | ﹤0.01% | 5495 |
|
|
2016
Q2 | $31K | Sell |
19,669
-19
| -0.1% | -$27 | ﹤0.01% | 5694 |
|
|
2016
Q1 | $23K | Sell |
19,688
-3
| -0% | -$4 | ﹤0.01% | 5872 |
|
|
2015
Q4 | $37K | Sell |
19,691
-2,005
| -9% | -$4.08K | ﹤0.01% | 5822 |
|
|
2015
Q3 | $56K | Sell |
21,696
-3,159
| -13% | -$6.95K | ﹤0.01% | 5682 |
|
|
2015
Q2 | $56K | Buy |
24,855
+20,670
| +494% | +$47K | ﹤0.01% | 5817 |
|
|
2015
Q1 | $10K | Buy |
4,185
+1,033
| +33% | +$2.63K | ﹤0.01% | 6216 |
|
|
2014
Q4 | $8K | Buy |
3,152
+2,300
| +270% | +$5.63K | ﹤0.01% | 6249 |
|
|
2014
Q3 | $2K | Hold |
852
| – | – | ﹤0.01% | 6433 |
|
|
2014
Q2 | $2K | Sell |
852
-683
| -44% | -$1.61K | ﹤0.01% | 6380 |
|
|
2014
Q1 | $4K | Buy |
+1,535
| New | +$4.1K | ﹤0.01% | 6270 |
|
Other funds holding AEHR
AIC
VCM
VPM
NCGI
Morgan Stanley's AEHR Position: Q1 2026 in Review
Morgan Stanley reduced its Aehr Test Systems (AEHR) stake by 32% in Q1 2026, selling an estimated $2.53M and leaving 165,673 shares worth $6.14M. The position accounts for ﹤0.01% of the portfolio, ranked #3976.
Morgan Stanley first reported a position in AEHR in Q1 2014 and has held it in 49 quarters since. The position peaked at $25.7M in Q3 2023. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.
- Morgan Stanley held 165,673 shares of Aehr Test Systems worth $6.14M as of Q1 2026.
- Morgan Stanley sold 79,110 Aehr Test Systems shares in Q1 2026, an estimated $2.53M.
- Aehr Test Systems made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #3976 holding.
- Morgan Stanley first reported a position in Aehr Test Systems in Q1 2014 and has held it in 49 quarters since.
- Morgan Stanley's Aehr Test Systems position peaked at $25.7M in Q3 2023.
- 191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.